The natural history of hepatitis C virus infection acquired during childhood

Liver International

Volumn 32, Issue 2, 2012, Pages 258-270

  Robinson, Joan L ^a   Doucette, Karen ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Hepatitis C; Liver disease; Liver failure; Outcome; Paediatric

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD TRANSFUSION; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CONGENITAL HEART DISEASE; DISEASE COURSE; DISEASE SEVERITY; GENOTYPE; HEART SURGERY; HEPATITIS C; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; STEATOSIS; SYSTEMATIC REVIEW; VIREMIA; VIRUS LOAD;

ADOLESCENT; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFANT; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LONGEVITY; MALE; PROGNOSIS; TREATMENT OUTCOME;

EID: 84855543596     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02633.x     Document Type: Article

References (48)

1. Hoshiyama A, Kimura A, Fujisawa T, Kage M, Kato H. Clinical and histologic features of chronic hepatitis C virus infection after blood transfusion in Japanese children. Pediatrics 2000;105(1 Pt 1):62-5.
2. Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105-11.
3. Rumbo C, Fawaz RL, Emre SH, et al. Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr 2006; 43: 209-16.
4. Luban NL, Colvin CA, Mohan P, Alter HJ. The epidemiology of transfusion-associated hepatitis C in a children's hospital. Transfusion 2007; 47: 615-20.
5. Matsuoka S, Tatara K, Hayabuchi Y, et al. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion. Pediatrics 1994; 94(6 Pt 1): 919-22.
6. Zucotti GV, Salvini F, Farina F, Agostini C, Riva E, Giovannini M. Longitudinal long-term follow-up study of children with vertically acquired hepatitis C virus infection. J Int Med Res 2006; 34: 215-22.
7. Fried MW, Kroner BL, Preiss LR, Wilhelmsen K, Goedert JJ, Multicenter Hemophilia Cohort Study. Hemophilic siblings with chronic hepatitis C: familial aggregation of spontaneous and treatment-related viral clearance. Gastroenterology 2006; 131: 757-64.
8. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005; 41: 45-51.
9. Tanaka E, Kiyosawa K, Sodeyama T, et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg 1992; 46: 460-4.
10. Blanchette VS, Vorstman E, Shore A, et al. Hepatitis C infection in children with hemophilia A and B. Blood 1991; 78: 285-9.
11. Di Marco V, Bronte F, Sicily Group for the Study of Thalassemia, et al. HCV clearance among hemophiliacs and beta-thalassemics. Gastroenterology 2007; 132: 1634.
12. Kocabas E, Aksaray N, Alhan E, Tanyeli A, Koksal F, Yarkin F. Hepatitis B and C virus infections in Turkish children with cancer. Eur J Epidemiol 1997; 13: 869-73.
13. Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A. Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr 1992; 151: 573-6.
14. Shebl FM, El-Kamary SS, Saleh DA, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol 2009; 81: 1024-31.
15. Lu SN, Chen HC, Tang CM, et al. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J 1998; 17: 142-5.
16. El-Sherbini A, Hassan W, Abdel-Hamid M, Naeim A. Natural history of hepatitis C virus among apparently normal schoolchildren: follow-up after 7 years. J Trop Pediatr 2003; 49: 384-5.
17. Davaalkham D, Ojima T, Nymadawa P, et al. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 2006; 78: 466-72.
18. El-Raziky MS, El-Hawary M, Esmat G, et al. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007; 13: 1828-32.
19. Wu TC, Chuang WL, Dai CY, et al. Hepatitis C virus infection among children in aboriginal areas in Taiwan. Trans R Soc Trop Med Hyg 2008; 102: 935-8.
20. Saleh DA, Shebl FM, El-Kamary SS, et al. Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Trans R Soc Trop Med Hyg 2010; 104: 357-63.
21. Kori M, Flidel-Rimon O, Sigler E, Shinwell E, Granot E. Look-back study of hepatitis C in teenagers after blood transfusions as neonates. Acta Paediatr 2007; 96: 1050-2.
22. Nelson SP, Jonas MM. Hepatitis C infection in children who received extracorporeal membrane oxygenation. J Pediatr Surg 1996; 31: 644-8.
23. Casiraghi MA, De Paschale M, Romano L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004; 39: 90-6.
24. Ni YH, Chang MH, Lue HC, et al. Posttransfusion hepatitis C virus infection in children. J Pediatr 1994; 124(5 Pt 1): 709-13.
25. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341: 866-70.
26. Fink FM, Hocker-Schulz S, Mor W, et al. Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients. Eur J Pediatr 1993; 152: 490-2.
27. Monteleone PM, Andrzejewski C, Kelleher JF. Prevalence of antibodies to hepatitis C virus in transfused children with cancer. Am J Pediatr Hematol Oncol 1994; 16: 309-13.
28. Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997; 90: 4628-33.
29. Utili R, Zampino R, Bellopede P, et al. Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood 1994; 99: 4046-52.
30. Castellino S, Lensing S, Riely C, et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St. Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 2004; 103: 2460-6.
31. Lin CY, Lin JY, Chen WP. Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan. Nephron 1993; 65: 654.
32. Lau YL, Chow CB, Lee AC, et al. Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major. Bone Marrow Transplant 1993; 12 (Suppl. 1): 26-8.
33. Zwiener RJ, Fielman BA, Cochran C, et al. Interferon-alpha-2b treatment of chronic hepatitis C in children with hemophilia. Pediatr Infect Dis J 1996; 15: 906-8.
34. Laosombat V, Pornpatkul M, Wongchanchailert M, Worachat K, Wiriyasatienku A. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand. Southeast Asian J Trop Med Public Health 1997; 28: 149-53.
35. Adamowicz-Salach A, Pawelec K, Loch T, et al. Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland. Haemophilia 1999; 5: 436-40.
36. Chang MH, Ni YH, Hwang LH, et al. Long term clinical and virologic outcome of primary hepatitis C virus infection in children: a prospective study. Pediatr Infect Dis J 1994; 13: 769-73.
37. Mohan P, Colvin C, Glymph C, et al. Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J Pediatr 2007; 150: 168-74.
38. Bortolotti F, Verucchi G, Camma C, et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134: 1900-7.
39. England K, Pembrey L, Tovo PA, Newell ML, European Paediatric HCV Network. Growth in the first 5 years of life is unaffected in children with perinatally-acquired hepatitis C infection. J Pediatr 2005; 147: 227-32.
40. Minola E, Prati D, Suter F, et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 2002; 99: 4588-91.
41. Henderson WA, Shankar R, Feld JJ, Hadigan CM. Symptomatic and pathophysiologic predictors of hepatitis C virus progression in pediatric patients. Pediatr Infect Dis J 2009; 28: 724-7.
42. Alisi A, Comparcola D, Nobili V. Treatment of chronic hepatitis C in children: is it necessary and, if so, in whom? J Hepatol 2010; 52: 472-4.
43. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
44. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
45. Barrett S, Goh J, Coughlan B, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001; 49: 423-30.
46. Iorio R, Giannattasio A, Sepe A, Terracciano LM, Vecchione R, Vegnente A. Chronic hepatitis C in childhood: an 18-year experience. Clin Infect Dis 2005; 41: 1431-7.
47. Goodman ZD, Makhlouf HR, Liu L, et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology 2008; 47: 836-43.
48. Iorio R, Cirillo F, Terlizzi V, Giannattasio A. Children with chronic hepatitis C: what future? Hepatology 2008; 48: 691-2.